Qi
Su
ab,
Changrong
Wang
c,
Huijuan
Song
d,
Chuangnian
Zhang
b,
Jinjian
Liu
*d,
Pingsheng
Huang
b,
Yumin
Zhang
d,
Jianhua
Zhang
*a and
Weiwei
Wang
*b
aDepartment of Polymer Science and Technology, Key Laboratory of Systems Bioengineering of the Ministry of Education, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China. E-mail: jhuazhang@tju.edu.cn
bTianjin Key Laboratory of Biomaterial Research Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China. E-mail: wwwangtj@163.com; wangww@bme.pumc.edu.cn
cSchool of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, Guanhai Road 346, Yantai 264003, China
dTianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China. E-mail: liujinjian2002@163.com
First published on 20th May 2021
Correction for ‘Co-delivery of anionic epitope/CpG vaccine and IDO inhibitor by self-assembled cationic liposomes for combination melanoma immunotherapy’ by Qi Su et al., J. Mater. Chem. B, 2021, 9, 3892–3899, DOI: 10.1039/d1tb00256b.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2021 |